{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:08:08Z","timestamp":1792616888644,"version":"4.5.0"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec id=\"ab-esc220002-1\"><jats:title>Importance<\/jats:title><jats:p>An ongoing global monkeypox virus outbreak in 2022 includes the US and other nonendemic countries. Monkeypox ophthalmic manifestations may present to the ophthalmologist, or the ophthalmologist may be involved in comanagement. This narrative review creates a primer for the ophthalmologist of clinically relevant information regarding monkeypox, its ophthalmic manifestations, and the 2022 outbreak.<\/jats:p><\/jats:sec><jats:sec id=\"ab-esc220002-2\"><jats:title>Observations<\/jats:title><jats:p>Monkeypox virus is an <jats:italic>Orthopoxvirus<\/jats:italic> (genus includes variola [smallpox] and vaccinia [smallpox vaccine]). The 2022 outbreak is of clade II (historically named West African clade), specifically subclade IIb. In addition to historic transmission patterns (skin lesions, bodily fluids, respiratory droplets), sexual transmission has also been theorized in the current outbreak due to disproportionate occurrence in men who have sex with men. Monkeypox causes a characteristic skin eruption and mucosal lesions and may cause ophthalmic disease. Monkeypox-related ophthalmic disease (MPXROD) includes a spectrum of ocular pathologies including eyelid\/periorbital skin lesions, blepharoconjunctivitis, and keratitis). Smallpox vaccination may reduce MPXROD occurrence. MPXROD seems to be rarer in the 2022 outbreaks than in historical outbreaks. MPXROD may result in corneal scarring and blindness. Historical management strategies for MPXROD include lubrication and prevention\/management of bacterial superinfection in monkeypox keratitis. Case reports and in vitro data for trifluridine suggest a possible role in MPXROD. Tecovirimat, cidofovoir, brincidofovir and vaccinia immune globulin intravenous may be used for systemic infection. There is a theoretical risk for monkeypox transmission by corneal transplantation, and the Eye Bank Association of America has provided guidance. Smallpox vaccines (JYNNEOS [Bavarian Nordic] and ACAM2000 [Emergent Product Development Gaithersburg Inc]) provide immunity against monkeypox.<\/jats:p><\/jats:sec><jats:sec id=\"ab-esc220002-3\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The ophthalmologist may play an important role in the diagnosis and management of monkeypox. MPXROD may be associated with severe ocular and visual morbidity. As the current outbreak evolves, up-to-date guidance from public health organizations and professional societies are critical.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2022.4567","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T15:33:16Z","timestamp":1667489596000},"page":"78","source":"Crossref","is-referenced-by-count":50,"title":["<i>Monkeypox Virus<\/i> and Ophthalmology\u2014A Primer on the 2022 Monkeypox Outbreak and Monkeypox-Related Ophthalmic Disease"],"prefix":"10.1001","volume":"141","author":[{"given":"Aaron R.","family":"Kaufman","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chodosh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston"},{"name":"Department of Ophthalmology & Visual Sciences, University of New Mexico School of Medicine, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Roberto","family":"Pineda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"esc220002r1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/v9120380","article-title":"Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research.","volume":"9","author":"Reynolds","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"esc220002r2","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1080\/22221751.2022.2095309","article-title":"Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters.","volume":"11","author":"Xiang","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"esc220002r3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jama.2022.10802","article-title":"Monkeypox in 2022: what clinicians need to know.","volume":"328","author":"Guarner","year":"2022","journal-title":"JAMA"},{"key":"esc220002r4","doi-asserted-by":"publisher","first-page":"o1874","DOI":"10.1136\/bmj.o1874","article-title":"Monkeypox: WHO declares a public health emergency of international concern.","volume":"378","author":"Taylor","year":"2022","journal-title":"BMJ"},{"key":"esc220002r7","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02195-z","article-title":"Ophthalmic manifestations of monkeypox virus.","author":"Abdelaal","journal-title":"Eye (Lond)"},{"key":"esc220002r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.4017","article-title":"Role of ophthalmology in emerging infectious diseases.","author":"Rose-Nussbaumer","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"esc220002r9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.2022.14857","article-title":"Update on the monkeypox outbreak.","volume":"328","author":"Del Rio","year":"2022","journal-title":"JAMA"},{"key":"esc220002r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102855","article-title":"The 2022 outbreak and the pathobiology of the monkeypox virus.","volume":"131","author":"Kumar","year":"2022","journal-title":"J Autoimmun"},{"issue":"2","key":"esc220002r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox: a potential threat? a systematic review.","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"esc220002r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004130","article-title":"further assessment of monkeypox virus infection in Gambian pouched rats (Cricetomys gambianus) using in vivo bioluminescent imaging.","volume":"9","author":"Falendysz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"esc220002r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001769","article-title":"Urgent need for a nondiscriminatory and nonstigmatizing nomenclature for monkeypox virus.","volume":"20","author":"Happi","year":"2022","journal-title":"PLoS Biol"},{"issue":"8","key":"esc220002r15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries: April-June 2022.","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"esc220002r16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072410","article-title":"Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series.","volume":"378","author":"Patel","year":"2022","journal-title":"BMJ"},{"key":"esc220002r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.08.012","article-title":"Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study.","author":"Mailhe","journal-title":"Clin Microbiol Infect"},{"issue":"29","key":"esc220002r18","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.29.2200552","article-title":"Paediatric monkeypox patient with unknown source of infection, the Netherlands, June 2022.","volume":"27","author":"Tutu van Furth","year":"2022","journal-title":"Euro Surveill"},{"issue":"2","key":"esc220002r19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients.","volume":"156","author":"Jezek","year":"1987","journal-title":"J Infect Dis"},{"issue":"12","key":"esc220002r20","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","article-title":"Clinical characteristics of human monkeypox and risk factors for severe disease.","volume":"41","author":"Huhn","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"esc220002r21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ophtha.2022.07.017","article-title":"Conjunctivitis with monkeypox virus positive conjunctival swabs.","volume":"129","author":"Meduri","year":"2022","journal-title":"Ophthalmology"},{"issue":"9","key":"esc220002r22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1473-3099(22)00504-7","article-title":"Ophthalmic manifestation of monkeypox infection.","volume":"22","author":"Benatti","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"esc220002r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.08.011","article-title":"Ocular involvement in monkeypox: description of an unusual presentation during the current outbreak.","author":"Mazzotta","journal-title":"J Infect"},{"key":"esc220002r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.3743","article-title":"Conjunctivitis in an individual with monkeypox.","author":"Ly-Yang","journal-title":"JAMA Ophthalmol"},{"key":"esc220002r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.3742","article-title":"Subconjunctival nodule in a patient with acute monkeypox.","author":"Foos","journal-title":"JAMA Ophthalmol"},{"key":"esc220002r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.3741","article-title":"A dome-shaped eyelid nodule in a young white man.","author":"Kontos","journal-title":"JAMA Ophthalmol"},{"issue":"42","key":"esc220002r29","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.15585\/mmwr.mm7142e1","article-title":"Ocular monkeypox: US, July-September 2022.","volume":"71","author":"Cash-Goldwasser","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"esc220002r30","doi-asserted-by":"publisher","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","article-title":"Status of human monkeypox: clinical disease, epidemiology and research.","volume":"29","author":"Damon","year":"2011","journal-title":"Vaccine"},{"key":"esc220002r31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijid.2014.03.994","article-title":"Ocular complications associated with acute monkeypox virus infection, DRC.","volume":"21S","author":"Hughes","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"2","key":"esc220002r32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4269\/ajtmh.2005.73.428","article-title":"Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003.","volume":"73","author":"Learned","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"esc220002r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.08.013","article-title":"Unilateral blepharoconjunctivitis due to monkeypox virus infection.","author":"Scandale","journal-title":"Ophthalmology"},{"issue":"5","key":"esc220002r34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archopht.121.5.715","article-title":"The ocular complications of smallpox and smallpox immunization.","volume":"121","author":"Semba","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"esc220002r35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac377","article-title":"Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, US.","volume":"9","author":"Matias","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"esc220002r36","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21790","article-title":"Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases.","author":"Catal\u00e0","journal-title":"Br J Dermatol"},{"issue":"7","key":"esc220002r41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJMp2210125","article-title":"Tecovirimat and the treatment of monkeypox: past, present, and future considerations.","volume":"387","author":"Sherwat","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"esc220002r43","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1128\/AAC.02814-14","article-title":"In vitro efficacy of brincidofovir against variola virus.","volume":"58","author":"Olson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"esc220002r44","first-page":"e00927","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model.","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"issue":"3","key":"esc220002r45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.","volume":"10","author":"Wittek","year":"2006","journal-title":"Int J Infect Dis"},{"issue":"4","key":"esc220002r46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/archopht.1965.00970040541019","article-title":"Therapy of experimental vaccinal keratitis: effect of idoxuridine and VIG.","volume":"74","author":"Fulginiti","year":"1965","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"esc220002r47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/infdis\/jiq103","article-title":"Evaluation of therapeutic interventions for vaccinia virus keratitis.","volume":"203","author":"Altmann","year":"2011","journal-title":"J Infect Dis"},{"key":"esc220002r49","doi-asserted-by":"publisher","DOI":"10.31646\/gbio.12","article-title":"Efficacy of 3 key antiviral drugs used to treat orthopoxvirus infections: a systematic review.","author":"Yu","journal-title":"Global Biosecur"},{"issue":"1-2","key":"esc220002r50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0166-3542(02)00198-5","article-title":"In vitro activity of potential antipoxvirus agents.","volume":"57","author":"Kern","year":"2003","journal-title":"Antiviral Res"},{"issue":"10345","key":"esc220002r51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0140-6736(22)01063-7","article-title":"Guidelines for pregnant individuals with monkeypox virus exposure.","volume":"400","author":"Dashraath","year":"2022","journal-title":"Lancet"},{"key":"esc220002r52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.07.022","article-title":"Monkeypox infection among men who have sex with men: PCR testing on seminal fluids.","author":"Raccagni","journal-title":"J Infect"},{"key":"esc220002r53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106768","article-title":"Monkeypox virus under COVID-19: caution for sexual transmission: correspondence.","volume":"104","author":"Zhu","year":"2022","journal-title":"Int J Surg"},{"key":"esc220002r54","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.v95.1","article-title":"Attaching a stigma to the LGBTQI+ community should be avoided during the monkeypox epidemic.","author":"Bragazzi","journal-title":"J Med Virol"},{"issue":"7","key":"esc220002r55","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1017\/ice.2022.152","article-title":"Monkeypox transmission following exposure in healthcare facilities in nonendemic settings: low risk but limited literature.","volume":"43","author":"Zachary","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"esc220002r57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jhin.2022.06.012","article-title":"Efficacy of biocidal agents and disinfectants against the monkeypox virus and other orthopoxviruses.","volume":"127","author":"Kampf","year":"2022","journal-title":"J Hosp Infect"},{"issue":"2","key":"esc220002r60","first-page":"123","article-title":"Newer poxvirus vaccine is recommended.","volume":"328","author":"Kuehn","year":"2022","journal-title":"JAMA"},{"key":"esc220002r24","author":"Croasdale","year":"2003"},{"key":"esc220002r5","unstructured":"World Health Organization. 2022 Monkeypox outbreak: global trends. Accessed November 28, 2022. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/"},{"key":"esc220002r6","unstructured":"Centers for Disease Control and Prevention. 2022 US map & case count. Accessed November 29, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/us-map.html"},{"key":"esc220002r12","unstructured":"Centers for Disease Control and Prevention. What health care professionals should know. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/what-hcps-should-know.html"},{"key":"esc220002r28","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for management of ocular monkeypox virus infection. Updated October 7, 2022. Accessed November 30, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/ocular-infection.html"},{"key":"esc220002r37","unstructured":"Centers for Disease Control and Prevention. Case definitions for use in the 2022 monkeypox response. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/case-definition.html"},{"key":"esc220002r38","unstructured":"Centers for Disease Control and Prevention. Case reporting recommendations for health departments. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/healthdepts\/case-reporting.html"},{"key":"esc220002r39","unstructured":"Centers for Disease Control and Prevention. Guidelines for collecting and handling specimens for monkeypox testing. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/prep-collection-specimens.html"},{"key":"esc220002r40","unstructured":"Centers for Disease Control and Prevention. Treatment information for health care professionals. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html"},{"key":"esc220002r42","unstructured":"Centers for Disease Control and Prevention. Guidance for tecovirimat use under expanded access investigational new drug protocol during 2022 US monkeypox outbreak. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/Tecovirimat.html"},{"key":"esc220002r48","unstructured":"Centers for Disease Control and Prevention. Clinical considerations for treatment and prophylaxis of monkeypox virus infection in people with HIV. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/people-with-HIV.html"},{"key":"esc220002r56","unstructured":"Centers for Disease Control and Prevention. Infection prevention and control of monkeypox in health care settings. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/infection-control-healthcare.html"},{"key":"esc220002r58","unstructured":"Centers for Disease Control and Prevention. Isolation and infection control at home. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/infection-control-home.html"},{"key":"esc220002r59","unstructured":"Eye Bank Association of America. Monkeypox informational alert: monkeypox and eye tissue donation. Accessed September 7, 2022. https:\/\/restoresight.org\/news\/monkeypox-informational-alert\/?utm_source=rss&utm_medium=rss&utm_campaign=monkeypox-informational-alert"},{"key":"esc220002r61","unstructured":"Centers for Disease Control and Prevention. Monkeypox and smallpox vaccine guidance. Accessed September 7, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html"},{"key":"esc220002r62","unstructured":"Administration for Strategic Preparedness and Response. JYNNEOS monkeypox vaccine distribution by jurisdiction. Accessed September 7, 2022.  https:\/\/aspr.hhs.gov\/SNS\/Pages\/JYNNEOS-Distribution.aspx"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2797919\/jamaophthalmology_kaufman_2022_sc_220002_1673287561.6365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T16:31:10Z","timestamp":1674145870000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2797919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4567","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}